Cancer Vaccines Technologies and Global Markets

1
Cancer Vaccines Technologies and Global Markets
2
Summary

• The global market for cancer vaccines was valued
  at nearly 4.2 billion and 4.0 billion in 2014
  and 2015, respectively. This market is expected
  to decline from nearly 3.5 billion in 2016 to
  3.4 billion in 2021 at a compound annual growth
  rate (CAGR) of -0.4 for 2016-2021.
• This report provides
• An overview of the global markets and
  technologies for cancer vaccines.
• Analyses of global market trends, with data from
  2014 and 2015, estimates for 2016, and
  projections of CAGRs through 2021.
• Coverage of the cancer vaccines arena including
  diverse therapeutic platform technologies,
  immune-stimulating agents and approved vaccines
  for cancer.
• Examination of the governmental and regulatory
  environment and how its effecting the market.
• Information on new developments including
  products in Phase I-IV clinical trials, as well
  as new technologies.

www.BharatBook.com
3
(No Transcript)
4
INTRODUCTION

• STUDY OBJECTIVES
• According to the World Health Organization,
  cancer has become the leading cause of death in
  recent years. Though cancer vaccines presently
  represent a minor share of the oncology industry,
  they are expected to be one of the most
  profitable segments for pharmaceutical companies
  over the forecast period. Most cancer vaccines
  work by improving a persons immune system,
  allowing it to attack cancer cells, and thus
  virus-induced cancers can be prevented using
  vaccines. Its goal in conducting this study is to
  provide an overview of the current and future
  dynamics of the global market for various cancer
  vaccines.
• This report explores present and future
  strategies within the cancer vaccines market,
  which includes prophylactic vaccines and
  therapeutic vaccines. The development of the
  market, the holdups and the needs of the market
  are discussed in this report. The classifications
  and usage of these vaccines are also discussed in
  this report.

www.BharatBook.com
5

• REASONS FOR DOING THIS STUDY
• Cancer vaccines are an important part of the
  biomedical industry. The sharp rise in cancer
  throughout the world is a consequence of combined
  genetic, social and environmental factors. Thus,
  the need for preventive as well as therapeutic
  vaccines is increasing progressively. Recently,
  some of the vaccines that help protect against
  viral infections have shown promising results to
  prevent some of these viral-induced cancers.
  Modern industries have now begun to explore the
  advantages of cancer vaccines in their
  productions and processes. Many government
  initiatives are encouraging researchers to
  develop cancer immunotherapies.
• The nature of the disease, expected increase in
  demand for cancer vaccines and higher
  profitability as compared with generic drugs are
  the growth factors of this market.
• Acquisition strategies and collaborations by
  companies are also covered in this report as well
  as the strengths and weaknesses of each type of
  vaccine in light of the new technologies, growing
  competition, and changing customer needs.

www.BharatBook.com
6

• CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE
• This study contributes to the areas of market
  growth for cancer vaccine manufacturers and
  users. Genomic research centers, academic
  institutions, government and private
  laboratories, as well as pharmaceutical,
  diagnostic and biotechnology companies, and
  physicians will find this study to be of
  interest.
• SCOPE OF THE STUDY
• The scope of this study entails the global market
  of cancer vaccines. The report covers the total
  market of cancer vaccines, which includes two
  main areas of applications, prophylactic vaccines
  and therapeutic vaccines. Human papillomavirus
  (HPV) vaccines and hepatitis B vaccines that
  indirectly act against cancer are also included
  in the report.
• The report also covers the global market of
  cancer vaccines by application in various cancer
  types such as prostate, liver, cervical and
  others such as lung and urinary bladder. It is
  discussed from both a commercial perspective and
  that of a research and development (RD)
  perspective.
• It analyzes each market and its application,
  regulatory environment, new products and
  advancements, market projections and market
  shares.

www.BharatBook.com
7

• METHODOLOGY
• Both primary and secondary research methodologies
  were used in preparing this study. It conducted a
  comprehensive literature search, which included
  technical newsletters and journals, and many
  other sources. Data were collected through
  interviews and correspondence with manufacturers
  and users of cancer vaccines. Projections were
  based on estimates such as the current number of
  end users, potential end users, mergers and
  acquisitions, and market trends.
• INFORMATION SOURCES
• Many companies were surveyed to obtain data for
  this study. Included were manufacturers and end
  users of cancer vaccines. Data was gathered from
  various industry sources. It spoke with officials
  within the industry, consulted newsletters,
  company literature, product literature, and a
  host of technical articles, journals, indexes,
  and abstracts. Exhaustive investigations of
  databases by key terminology were completed. In
  addition, data were compiled from current
  financial, trade, and government sources.

www.BharatBook.com
8
Table of Contents

• Introduction
• Executive Summary
• Overview
• Regulatory Aspects
• New Developments
• Market Analysis
• Industry Structure
• Market By Application
• Patent Analysis
• Current Situation
• Company Profiles
• Abbreviations

www.BharatBook.com
9
Full Reports
Cancer Vaccines Technologies Global Markets
Bharat Book Bureau Tel [phone] /
27810773 Email poonam_at_bharatbook.com Website
www.bharatbook.com FaceBook BharatBook3B Twitter
ResearchBook LinkedIn Bharat Book Bureau